Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study
- PMID: 36143934
- PMCID: PMC9505554
- DOI: 10.3390/medicina58091257
Antibiotic Abuse and Antimicrobial Resistance in Hospital Environment: A Retrospective Observational Comparative Study
Abstract
Background and Objectives: Antimicrobial resistance represents a serious problem, and it may be life-threatening in the case of severe hospital-acquired infections (HAI). Antibiotic abuse and multidrug resistance (MDR) have significantly increased this burden in the last decades. The aim of this study was to investigate the distribution and susceptibility rates of five selected bacterial species (E. coli, K. pneumoniae, P. aeruginosa, S. aureus and E. faecium) in two healthcare settings located in the Apulia region (Italy). Materials and Methods: Setting n.1 was a university hospital and setting n.2 was a research institute working on oncological patients. All the enrolled patients were diagnosed for bacterial HAI. The observation period was between August and September 2021. Clinical samples were obtained from several biological sources, in different hospital wards. Bacterial identification and susceptibility were tested by using the software VITEC 2 Single system. Results: In this study, a higher incidence of multi-drug-resistant K. pneumoniae was reported (42,2% in setting n.1 and 50% in setting n.2), with respect to the Italian 2019 statistics report (30.3%). All the isolates of E. faecium and S. aureus were susceptible to linezolid. All the bacterial isolates of P. aeruginosa and most of K. pneumoniae were susceptible to ceftazidime-avibactam. Amikacin and nitrofurantoin represented a good option for treating E. coli infections. Multidrug-resistant (MDR) P. aeruginosa, methicillin-resistant S. aureus (MRSA) and vancomycin-resistantE. faecium (VRE) had a lower incidence in the clinical setting, with respect to E. coli and K. pneumoniae. Conclusions: The data obtained in this study can support clinicians towards a rational and safe use of antibiotics for treating the infections caused by these resistant strains, to enhance the overall efficacy of the current antibiotic protocols used in the main healthcare environments.
Keywords: antibiotics; antimicrobial resistance; bacterial isolates; clinical setting; infections; multidrug resistance.
Conflict of interest statement
The authors declare no conflict of interest.
Similar articles
-
[Analysis of pathogen spectrum and antimicrobial resistance of pathogens associated with hospital-acquired infections collected from 11 teaching hospitals in 2018].Zhonghua Yi Xue Za Zhi. 2020 Dec 22;100(47):3775-3783. doi: 10.3760/cma.j.cn112137-20200430-01389. Zhonghua Yi Xue Za Zhi. 2020. PMID: 33379842 Chinese.
-
The tigecycline evaluation and surveillance trial; assessment of the activity of tigecycline and other selected antibiotics against gram-positive and gram-negative pathogens from France collected between 2004 and 2016.Antimicrob Resist Infect Control. 2018 May 30;7:68. doi: 10.1186/s13756-018-0360-y. eCollection 2018. Antimicrob Resist Infect Control. 2018. PMID: 29876099 Free PMC article.
-
[Microbiological profiles of pathogens causing nosocomial bacteremia in 2011, 2013 and 2016].Sheng Wu Gong Cheng Xue Bao. 2018 Aug 25;34(8):1205-1217. doi: 10.13345/j.cjb.180192. Sheng Wu Gong Cheng Xue Bao. 2018. PMID: 30152206 Chinese.
-
Literature review on the distribution characteristics and antimicrobial resistance of bacterial pathogens in neonatal sepsis.J Matern Fetal Neonatal Med. 2022 Mar;35(5):861-870. doi: 10.1080/14767058.2020.1732342. Epub 2020 Feb 26. J Matern Fetal Neonatal Med. 2022. PMID: 32102584 Review.
-
Antimicrobial resistance in Libya: 1970-2011.Libyan J Med. 2013 Mar 27;8(1):20567. doi: 10.3402/ljm.v8i0.20567. Libyan J Med. 2013. PMID: 23537612 Free PMC article. Review.
Cited by
-
The Global Challenge of Antimicrobial Resistance: Mechanisms, Case Studies, and Mitigation Approaches.Health Sci Rep. 2025 Jul 23;8(7):e71077. doi: 10.1002/hsr2.71077. eCollection 2025 Jul. Health Sci Rep. 2025. PMID: 40704322 Free PMC article.
-
Global trends of ceftazidime-avibactam resistance in gram-negative bacteria: systematic review and meta-analysis.Antimicrob Resist Infect Control. 2025 Feb 11;14(1):10. doi: 10.1186/s13756-025-01518-5. Antimicrob Resist Infect Control. 2025. PMID: 39934901 Free PMC article.
-
Pharmacies and use of antibiotics: a cross sectional study in 19 Arab countries.Antimicrob Resist Infect Control. 2024 Sep 18;13(1):104. doi: 10.1186/s13756-024-01458-6. Antimicrob Resist Infect Control. 2024. PMID: 39294829 Free PMC article.
-
Enhanced Antibacterial Activity of Hydrophobic Modified Lysozyme Against Gram-Negative Bacteria Without Accumulated Resistance.Molecules. 2025 Jan 9;30(2):232. doi: 10.3390/molecules30020232. Molecules. 2025. PMID: 39860102 Free PMC article.
-
The Pivotal Role of Presepsin in Assessing Sepsis-Induced Cholestasis.Diagnostics (Basel). 2024 Aug 6;14(16):1706. doi: 10.3390/diagnostics14161706. Diagnostics (Basel). 2024. PMID: 39202194 Free PMC article.
References
-
- Condò R., Mampieri G., Pasquantonio G., Giancotti A., Pirelli P., Cataldi M.E., La Rocca S., Leggeri A., Notargiacomo A., Maiolo L., et al. In vitro evaluation of structural factors favouring bacterial adhesion on orthodontic adhesive resins. Materials. 2021;14:2485. doi: 10.3390/ma14102485. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical